Nasdaq - Delayed Quote
USD
BlackRock Health Sciences Opps Inv A (SHSAX)
68.64
0.00
(0.00%)
As of 10:23:50 AM EDT. Market Open.
Performance Overview
| Morningstar Return Rating | -- |
| YTD Return | 14.11% |
|---|---|
| 5y Average Return | 6.77% |
| Number of Years Up | 22 |
| Number of Years Down | 4 |
| Best 1Y Total Return (Oct 27, 2026) | 44.15% |
| Worst 1Y Total Return (Oct 27, 2026) | -- |
| Best 3Y Total Return | 44.15% |
| Worst 3Y Total Return | 0.40% |
Trailing Returns (%) Vs. Benchmarks
Monthly Total Returns
SHSAX
Category
- YTD
- 10.07%
- 7.95%
- 1-Month
- -0.74%
- 4.81%
- 3-Month
- 5.42%
- 7.18%
- 1-Year
- 23.04%
- 30.16%
- 3-Year
- 11.94%
- 16.10%
- 5-Year
- 6.60%
- 15.71%
- 10-Year
- 10.66%
- 15.27%
- Last Bull Market
- 17.22%
- 23.06%
- Last Bear Market
- -5.98%
- -13.88%
Annual Total Return (%) History
Year
SHSAX
Category
Past Quarterly Returns
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
|
2026
|
-4.62% | 9.48% | 5.42% | -- |
|
2025
|
3.60% | -4.58% | 4.95% | 11.78% |
|
2024
|
8.69% | 0.70% | 4.18% | -8.92% |
|
2023
|
-2.44% | 4.33% | -3.82% | 5.79% |
|
2022
|
-5.86% | -5.98% | -5.27% | 12.21% |
|
2021
|
0.11% | 7.36% | -2.36% | 6.52% |
|
2020
|
-11.54% | 17.47% | 6.36% | 8.09% |
|
2019
|
8.79% | 1.89% | -1.65% | 14.93% |
|
2018
|
0.02% | 6.49% | 12.90% | -10.22% |
|
2017
|
10.40% | 7.88% | 3.19% | 1.56% |
Rank in Category (By Total Return)
| YTD | 56 |
| 1-Month | 30 |
|---|---|
| 3-Month | 38 |
| 1-Year | 58 |
| 3-Year | 63 |
| 5-Year | 28 |
Load Adjusted Returns
| 1-Year | 16.58% |
| 3-Year | 9.95% |
|---|---|
| 5-Year | 5.45% |
| 10-Year | 10.07% |
Performance & Risk
| YTD Return | 14.11% |
| 5y Average Return | 6.77% |
| Rank in Category (ytd) | 56 |
| % Rank in Category (ytd) | -- |
| Beta (5Y Monthly) | 0.52 |
| Morningstar Risk Rating |
Fund Overview
| Category | Health |
| Fund Family | BlackRock |
| Net Assets | 6.26B |
| YTD Return | 10.07% |
| Yield | 0.26% |
| Morningstar Rating | |
| Inception Date | Oct 16, 2000 |
Fund Summary
The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.
